The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Axonal loss and neuroinflammation caused by peroxisome-deficient oligodendrocytes
Open accessAbstract
Oligodendrocytes myelinate axons for rapid impulse conduction and contribute to normal axonal functions in the central nervous system. In multiple sclerosis, demyelination is caused by autoimmune attacks, but the role of oligodendroglial cells in disease progression and axon degeneration is unclear. Here we show that oligodendrocytes harbor peroxisomes whose function is essential for maintaining white matter tracts throughout adult life. By selectively inactivating the import factor PEX5 in myelinating glia, we generated mutant mice that developed normally, but within several months showed ataxia, tremor and premature death. Absence of functional peroxisomes from oligodendrocytes caused widespread axonal degeneration and progressive subcortical demyelination, but did not interfere with glial survival. Moreover, it caused a strong proinflammatory milieu and, unexpectedly, the infiltration of B and activated CD8+ T cells into brain lesions. We conclude that peroxisomes provide oligodendrocytes with an essential neuroprotective function against axon degeneration and neuroinflammation, which is relevant for human demyelinating diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the 2′,3′-cyclic nucleotide 3′-phosphodiesterase (CNP)-Pex5 mouse brain, VLCFA accumulation is prominent in OLs, notable in astrocytes, and non-existent in neurons [166].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“Brain OLs account for the majority of VLCFA synthesis [166,204] by using their ELOVL1 [205,206,207,208].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“OL peroxisomes are largely responsible for VLCFA synthesis [204] and degradation [166] in the adult brain.”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“This CNP-Pex5 mutant mouse provided a striking phenocopy of human cALD, with disease onset following normal developmental myelination.”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“The brains of these mice showed strong VLCFA accumulation in myelin, severe axonal loss, severely lower plasmalogen levels, and early microglial increase in white matter, followed by demyelination with characteristic regional variability and inflammation with infiltrating perivascular macrophages and B and T cells.”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“Their peroxisome content is abundant [166,253,315], and they express abundant ALDP in normal microglia in human and mouse brains [156].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“Astrocytes in GFAP-Pex5 KO mice have strong VLCFA accumulation, albeit inferior to that seen in the OLs of CNP-Pex5 KO mice [166,264].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“X-ALD pathogenesis seems to be governed by two major mechanisms acting primarily in OLs: VLCFA accumulation, which causes AMN and is cALD permissive, and a secondary peroxisomal pathology, suggested to be a necessary added mechanism of cALD [166].”
From Revisiting the Pathogenesis of X-Linked Adrenoleukodystrophy (2025) · cites this paper as [166]
In the citing paper
“Similarly, selective knockout (KO) of Pex5 in oligodendrocytes by using Cnp-Cre drivers had severe consequences for the adult brain [75].”
From Peroxisomes in brain development and function (2016) · cites this paper as [75]
In the citing paper
“This hypothesis is based on the observation that mice lacking functional peroxisomes in oligodendrocytes initially show normal myelination, but develop axonal swelling followed by cerebral demyelination and infiltration of inflammatory T cells [94].”
From X-linked adrenoleukodystrophy: Clinical, metabolic, genetic and pathophysiological aspects (2012) · cites this paper as [94]
Citations
Cites
A RAPID METHOD OF TOTAL LIPID EXTRACTION AND PURIFICATION
Bligh, E. G., & Dyer, W. J. (1959) · Canadian Journal of Biochemistry and Physiology · doi:10.1139/o59-099 · Cited by 54,751
Axonal transection in the lesions of multiple sclerosis
Trapp, B. D., Peterson, J., Ransohoff, R. M., Rudick, R., Mörk, S., & Bö, L. (1998) · New England Journal of Medicine · doi:10.1056/nejm199801293380502 · Cited by 4,029
MYELINATION IN RAT BRAIN: METHOD OF MYELIN ISOLATION1
Norton, W. T., & Poduslo, S. E. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb07519.x · Cited by 1,413
Putative X-linked adrenoleukodystrophy gene shares unexpected homology with ABC transporters
Mosser, J., Douar, A.-M., Sarde, C.-O., Kioschis, P., Feil, R., Moser, H., Poustka, A.-M., Mandel, J.-L., & Aubourg, P. (1993) · Nature · doi:10.1038/361726a0 · Cited by 1,202
Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion
Barnett, M. H., & Prineas, J. W. (2004) · Annals of Neurology · doi:10.1002/ana.20016 · Cited by 1,184
Disruption of Cnp1 uncouples oligodendroglial functions in axonal support and myelination
Lappe-Siefke, C., Goebbels, S., Gravel, M., Nicksch, E., Lee, J., Braun, P. E., Griffiths, I. R., & Nave, K.-A. (2003) · Nature Genetics · doi:10.1038/ng1095 · Cited by 1,036
Self-citationSilver Staining of Myelin by Means of Physical Development
Gallyas, F. (1979) · Neurological Research · doi:10.1080/01616412.1979.11739553 · Cited by 936
Axonal Swellings and Degeneration in Mice Lacking the Major Proteolipid of Myelin
Griffiths, I., Klugmann, M., Anderson, T., Yool, D., Thomson, C., Schwab, M. H., Schneider, A., Zimmermann, F., McCulloch, M., Nadon, N., et al. (1998) · Science · doi:10.1126/science.280.5369.1610 · Cited by 889
Self-citationPeroxisomes and oxidative stress
Schrader, M., & Fahimi, H. D. (2006) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.09.006 · Cited by 838
High cholesterol level is essential for myelin membrane growth
Saher, G., Brügger, B., Lappe-Siefke, C., Möbius, W., Tozawa, R.-I., Wehr, M. C., Wieland, F., Ishibashi, S., & Nave, K.-A. (2005) · Nature Neuroscience · doi:10.1038/nn1426 · Cited by 799
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Bielschowsky, M. Die Silberimprägnation der Neurofibrillen. J. Psychol. Neurol. 3, 169–183 (1904).
Cited by
Sorted by citations
Items 101–200 of 359
Aubourg, P. R., & Wanders, R. J. A. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-59565-2.00028-9 · Cited by 75
Environmental factors and their regulation of immunity in multiple sclerosis
Koch, M. W., Metz, L. M., Agrawal, S. M., & Yong, V. W. (2012) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2012.10.021 · Cited by 82
Myelin peroxisomes–Essential organelles for the maintenance of white matter in the nervous system
Kassmann, C. M. (2014) · Biochimie · doi:10.1016/j.biochi.2013.09.020 · Cited by 72
Self-citationAn emerging role of dysfunctional axon-oligodendrocyte coupling in neurodegenerative diseases
Mot, A. I., Depp, C., & Nave, K. (2018) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2018.20.4/amot · Cited by 72
Self-citationOligodendrocyte Precursor Cells in Spinal Cord Injury: A Review and Update
Li, N., & Leung, G. (2015) · BioMed Research International · doi:10.1155/2015/235195 · Cited by 76
Neuroimaging and Neurodevelopmental Outcomes in Preterm Infants
Hintz, S. R., & O’Shea, T. M. (2008) · Seminars in Perinatology · doi:10.1053/j.semperi.2007.12.010 · Cited by 70
Thyroid Hormone Signaling in Oligodendrocytes: from Extracellular Transport to Intracellular Signal
Lee, J. Y., & Petratos, S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0013-1 · Cited by 71
Qu, W., Johnson, A., Kim, J. H., Lukowicz, A., Svedberg, D. A., & Cvetanović, M. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0880-z · Cited by 65
Chen, H., Liu, Z., & Huang, X. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp518 · Cited by 68
Bottelbergs, A., Verheijden, S., Van Veldhoven, P. P., Just, W., Devos, R., & Baes, M. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-61 · Cited by 66
Self-citationAntioxidant cytoprotection by peroxisomal peroxiredoxin-5
Walbrecq, G., Wang, B., Becker, S., Hannotiau, A., Fransen, M., & Knoops, B. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.02.032 · Cited by 66
Mouse models for peroxisome biogenesis defects and β-oxidation enzyme deficiencies
Baes, M. I., & Veldhoven, P. P. V. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.03.003 · Cited by 70
Self-citationMars, L. T., Saikali, P., Liblau, R., & Arbour, N. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.006 · Cited by 70
Peroxisomes, myelination, and axonal integrity in the CNS
Baes, M., & Aubourg, P. (2009) · The Neuroscientist · doi:10.1177/1073858409336297 · Cited by 65
Self-citationLin, J.-P., Mironova, Y. A., Shrager, P., & Giger, R. J. (2017) · eLife · doi:10.7554/elife.30498 · Cited by 64
Paintlia, A. S., Paintlia, M. K., Mohan, S., Singh, A. K., & Singh, I. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.04.030 · Cited by 63
Oligodendroglial impact on axonal function and survival – a hypothesis
Kassmann, C. M., & Nave, K. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328300c71f · Cited by 63
Self-citationCermenati, G., Audano, M., Giatti, S., Carozzi, V., Porretta‐Serapiglia, C., Pettinato, E., Ferri, C., D’Antonio, M., Fabiani, E. D., Crestani, M., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.02.016 · Cited by 61
Rodrigues, G., Gaj, T., Adil, M. M., Wahba, J. M., Rao, A. T., Lorbeer, F. K., Kulkarni, R. U., Diogo, M. M., Cabral, J. M. S., Miller, E. W., et al. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.04.027 · Cited by 64
Patel, J., & Balabanov, R. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms130810647 · Cited by 61
Targeted Ablation of Oligodendrocytes Triggers Axonal Damage
Ghosh, A., Manrique‐Hoyos, N., Voigt, A., Schulz, J. B., Kreutzfeldt, M., Merkler, D., & Simons, M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022735 · Cited by 60
Abe, Y., Honsho, M., Nakanishi, H., Taguchi, R., & Fujiki, Y. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.01.001 · Cited by 59
Therapy of X-linked adrenoleukodystrophy
Moser, H. W. (2006) · NeuroRx · doi:10.1016/j.nurx.2006.01.004 · Cited by 59
Cerebral MRI as a valuable diagnostic tool in Zellweger spectrum patients
Weller, S., Rosewich, H., & Gärtner, J. (2008) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-008-0856-3 · Cited by 58
Ahlemeyer, B., Gottwald, M., & Baumgart‐Vogt, E. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.007708 · Cited by 57
de Monasterio‐Schrader, P., Patzig, J., Möbius, W., Barrette, B., Wagner, T. L., Kusch, K., Edgar, J. M., Brophy, P., & Werner, H. B. (2013) · Glia · doi:10.1002/glia.22561 · Cited by 58
Self-citationKruska, N., Schönfeld, P., Pujol, A., & Reiser, G. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.01.005 · Cited by 56
Dias-Carvalho, A., Ferreira, M., Ferreira, R. M., Bastos, M. D. L., Sá, S. I., Capela, J. P., Carvalho, F. D., & Costa, V. M. (2021) · Archives of Toxicology · doi:10.1007/s00204-021-03171-4 · Cited by 59
Leukodystrophies with late disease onset: an update
Köhler, W. (2010) · Current Opinion in Neurology · doi:10.1097/wco.0b013e328338313a · Cited by 54
Verheijden, S., Bottelbergs, A., Krysko, O., Krysko, D. V., Beckers, L., De Munter, S., Van Veldhoven, P. P., Wyns, S., Kulik, W., Nave, K.-A., et al. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.06.006 · Cited by 54
Self-citationA microglial cell model for acyl-CoA oxidase 1 deficiency
Raas, Q., Saih, F.-E., Gondcaille, C., Trompier, D., Hamon, Y., Leoni, V., Caccia, C., Nasser, B., Jadot, M., Ménétrier, F., et al. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2018.10.005 · Cited by 57
Multiple sclerosis: immunopathogenesis and controversies in defining the cause
Holmøy, T., & Hestvik, A. L. K. (2008) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282f88b48 · Cited by 56
Nury, T., Sghaier, R., Zarrouk, A., Ménétrier, F., Uzun, T., Leoni, V., Caccia, C., Meddeb, W., Namsi, A., Sassi, K., et al. (2018) · Biochimie · doi:10.1016/j.biochi.2018.07.009 · Cited by 54
A role for myelin-associated peroxisomes in maintaining paranodal loops and axonal integrity
Kassmann, C. M., Quintes, S., Rietdorf, J., Möbius, W., Sereda, M. W., Nientiedt, T., Saher, G., Baes, M., & Nave, K.-A. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.032 · Cited by 52
Self-citationRevisiting the neuropathogenesis of Zellweger syndrome
Crane, D. I. (2014) · Neurochemistry International · doi:10.1016/j.neuint.2014.02.007 · Cited by 51
Baarine, M., Ragot, K., Genin, E. C., Hajj, H. I. E., Trompier, D., Andreoletti, P., Ghandour, M. S., Ménétrier, F., Cherkaoui‐Malki, M., Savary, S., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06311.x · Cited by 57
Peroxisome biogenesis and human peroxisome-deficiency disorders
Fujiki, Y. (2016) · Proceedings of the Japan Academy Series B · doi:10.2183/pjab.92.463 · Cited by 51
In Vivo Imaging and Noninvasive Ablation of Pyramidal Neurons in Adult NEX-CreERT2 Mice
Agarwal, A., Dibaj, P., Kassmann, C. M., Goebbels, S., Nave, K., & Schwab, M. H. (2011) · Cerebral Cortex · doi:10.1093/cercor/bhr214 · Cited by 44
Self-citationTherapy of X-linked adrenoleukodystrophy
Semmler, A., Köhler, W., Jung, H. H., Weller, M., & Linnebank, M. (2008) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.8.9.1367 · Cited by 49
Modeling Psychiatric Disorder Biology with Stem Cells
Das, D., Feuer, K. L., Wahbeh, M. H., & Avramopoulos, D. (2020) · Current Psychiatry Reports · doi:10.1007/s11920-020-01148-1 · Cited by 49
Peroxisome biogenesis disorders: Molecular basis for impaired peroxisomal membrane assembly
Fujiki, Y., Yagita, Y., & Matsuzaki, T. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.06.004 · Cited by 48
Reductions in neuronal peroxisomes in multiple sclerosis grey matter
Gray, E., Rice, C., Hares, K., Redondo, J., Kemp, K., Williams, M., Brown, A. Y., Scolding, N., & Wilkins, A. (2014) · Multiple Sclerosis · doi:10.1177/1352458513505691 · Cited by 40
C26:0-Carnitine Is a New Biomarker for X-Linked Adrenoleukodystrophy in Mice and Man
van de Beek, M.-C., Dijkstra, I. M. E., van Lenthe, H., Ofman, R., Goldhaber-Pasillas, D., Schauer, N., Schackmann, M., Engelen-Lee, J.-Y., Vaz, F. M., Kulik, W., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0154597 · Cited by 48
Zheng, W., Li, Q., Zhao, C., Da, Y., Zhang, H., & Chen, Z. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00239 · Cited by 50
Peroxisomes as dynamic organelles: peroxisomal matrix protein import
Wolf, J., Schliebs, W., & Erdmann, R. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07739.x · Cited by 47
Neuron‐microglia interaction induced bi‐directional cytotoxicity associated with calpain activation
Podbielska, M., Das, A., Smith, A. W., Chauhan, A., Ray, S. K., Inoue, J., Azuma, M., Nozaki, K., Hogan, E. L., & Banik, N. L. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13774 · Cited by 50
Wangler, M. F., Chao, Y.-H., Bayat, V., Γιαγτζόγλου, Ν., Shinde, A. B., Putluri, N., Coarfa, C., Donti, T. R., Graham, B. H., Faust, J. E., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006825 · Cited by 47
Self-citationRole of peroxisomes in human lipid metabolism and its importance for neurological development
Wanders, R. J. A., & Poll-The, B. T. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2015.06.018 · Cited by 46
Strachan, L. R., Stevenson, T. J., Freshner, B., Keefe, M. D., Miranda Bowles, D., & Bonkowsky, J. L. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx249 · Cited by 46
Pathoetiology of multiple sclerosis: are we barking up the wrong tree?
Stys, P. K. (2013) · F1000Prime Reports · doi:10.12703/p5-20 · Cited by 47
Kleinecke, S., Richert, S., de Hoz, L., Brügger, B., Kungl, T., Asadollahi, E., Quintes, S., Blanz, J., McGonigal, R., Naseri, K., et al. (2017) · eLife · doi:10.7554/elife.23332 · Cited by 46
Self-citationNuccio, C. D., Bernardo, A., Simone, R. D., Mancuso, E., Magnaghi, V., Visentin, S., & Minghetti, L. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3182309ab1 · Cited by 45
Concepts for regulation of axon integrity by enwrapping glia
Beirowski, B. (2013) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2013.00256 · Cited by 47
Baarine, M., Ragot, K., Athias, A., Nury, T., Kattan, Z., Genin, E. C., Andreoletti, P., Ménétrier, F., Riedinger, J.-M., Bardou, M., et al. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2011.10.007 · Cited by 43
Linker, R. A., & Lee, D.-H. (2009) · Experimental & Translational Stroke Medicine · doi:10.1186/2040-7378-1-5 · Cited by 43
The Myelin Mutants as Models to Study Myelin Repair in the Leukodystrophies
Duncan, I. D., Kondo, Y., & Zhang, S. (2011) · Neurotherapeutics · doi:10.1007/s13311-011-0080-y · Cited by 44
Reversible reduction in brain myelin content upon marathon running
Ramos‐Cabrer, P., Cabrera‐Zubizarreta, A., Padró, D., Matute‐González, M., Rodríguez-Antigüedad, A., & Matute, C. (2025) · Nature Metabolism · doi:10.1038/s42255-025-01244-7 · Cited by 46
Plemel, J. R., Chojnacki, A. K., Sparling, J. S., Liu, J., Plunet, W. T., Duncan, G. J., Park, S. E., Weiss, S., & Tetzlaff, W. (2011) · Glia · doi:10.1002/glia.21232 · Cited by 41
Paintlia, M. K., Paintlia, A. S., Khan, M., Singh, I., & Singh, A. K. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05199.x · Cited by 41
Oligodendroglial Cells and Neurotrophins: A Polyphonic Cantata in Major and Minor
Althaus, H. H., Klöppner, S., Klopfleisch, S., & Schmitz, M. (2008) · Journal of Molecular Neuroscience · doi:10.1007/s12031-008-9053-y · Cited by 41
Luo, R., Fan, Y., Yang, J., Ye, M., Zhang, D., Guo, K., Li, X., Bi, R., Xu, M., Yang, L.-X., et al. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00748-4 · Cited by 41
Gray, E., Ginty, M., Kemp, K. C., Scolding, N. J., & Wilkins, A. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07637.x · Cited by 38
Seven-Tesla proton magnetic resonance spectroscopic imaging in adult X-linked adrenoleukodystrophy
Ratai, E., Kok, T., Wiggins, C., Wiggins, G., Grant, E., Gagoski, B., O’Neill, G., Adalsteinsson, E., & Eichler, F. (2008) · Archives of Neurology · doi:10.1001/archneur.65.11.1488 · Cited by 37
Axonal Damage in Leukodystrophies
Mar, S., & Noetzel, M. J. (2010) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2009.08.011 · Cited by 37
White matter lactate – Does it matter?
Rinholm, J. E., & Bergersen, L. H. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.10.002 · Cited by 38
Peroxisome deficient invertebrate and vertebrate animal models
Veldhoven, P. P. V., & Baes, M. I. (2013) · Frontiers in Physiology · doi:10.3389/fphys.2013.00335 · Cited by 37
Self-citationGruenenfelder, F. I., Thomson, G., Penderis, J., & Edgar, J. M. (2011) · Journal of Anatomy · doi:10.1111/j.1469-7580.2011.01363.x · Cited by 39
Interplay between Zika Virus and Peroxisomes during Infection
Wong, C. P., Xu, Z., Hou, S., Limonta, D., Kumar, A., Power, C., & Hobman, T. C. (2019) · Cells · doi:10.3390/cells8070725 · Cited by 36
Matsukawa, T., Asheuer, M., Takahashi, Y., Goto, J., Suzuki, Y., Shimozawa, N., Takano, H., Onodera, O., Nishizawa, M., Aubourg, P., et al. (2011) · neurogenetics · doi:10.1007/s10048-010-0253-6 · Cited by 36
Ren, Z., Wang, Y., Tao, D., Liebenson, D., Liggett, T., Goswami, R., Clarke, R. C., Stefoski, D., & Balabanov, R. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.1028-11.2011 · Cited by 34
Pex11a deficiency causes dyslipidaemia and obesity in mice
Chen, C., Wang, H., Chen, B., Chen, D., Lu, C., Li, H., Qian, Y., Tan, Y., Weng, H., & Cai, L. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14108 · Cited by 34
Defective Oligodendroglial Lineage and Demyelination in Amyotrophic Lateral Sclerosis
Traiffort, É., Morisset‐Lopez, S., Moussaed, M., & Zahaf, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073426 · Cited by 36
Oligodendrocytes in neurodegenerative diseases
Liu, Y., & Zhou, J. (2013) · Frontiers in Biology · doi:10.1007/s11515-013-1260-4 · Cited by 36
Ge, D., Song, K., Guan, S., Qi, Y., Guan, B., Li, W., Liu, J., Ma, X., Liu, T., & Cui, Z. (2013) · Applied Biochemistry and Biotechnology · doi:10.1007/s12010-013-0211-5 · Cited by 33
Sandström, J., Antinori, P., Zurich, M., Rosset, R., Aschner, M., Glück, F., Scherl, A., & Monnet‐Tschudi, F. (2014) · NeuroToxicology · doi:10.1016/j.neuro.2014.04.005 · Cited by 33
Slowly Progressive Axonal Degeneration in a Rat Model of Chronic, Nonimmune-Mediated Demyelination
Wilkins, A., Kondo, Y., Song, J. C., Liu, S., Compston, A., Black, J. A., Waxman, S. G., & Duncan, I. D. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ffc317 · Cited by 33
Kawade, N., & Yamanaka, K. (2023) · FEBS Open Bio · doi:10.1002/2211-5463.13661 · Cited by 35
Groh, J., & Martini, R. (2017) · Glia · doi:10.1002/glia.23162 · Cited by 32
Peroxisome Biogenesis: Something Old, Something New, Something Borrowed
Mast, F. D., Fagarasanu, A. D., Knoblach, B., & Rachubinski, R. A. (2010) · Physiology · doi:10.1152/physiol.00025.2010 · Cited by 32
Myelin lesions associated with lysosomal and peroxisomal disorders
Faust, P. L., Kaye, E. M., & Powers, J. M. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.127 · Cited by 31
Rivellini, C., Porrello, E., Dina, G., Mrakic-Sposta, S., Vezzoli, A., Bacigaluppi, M., Gullotta, G. S., Chaabane, L., Leocani, L., Marenna, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145071 · Cited by 32
Self-citationPoutiainen, P., Jaronen, M., Quintana, F. J., & Brownell, A. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00085 · Cited by 33
Martins‐Macedo, J., Lepore, A. C., Domingues, H. S., Salgado, A. J., Gomes, E. D., & Pinto, L. (2020) · Glia · doi:10.1002/glia.23922 · Cited by 31
Singh, I., Singh, A., & Contreras, M. (2009) · Journal of Child Neurology · doi:10.1177/0883073809338327 · Cited by 28
Emerging cellular themes in leukodystrophies
Nowacki, J. C., Fields, A. M., & Fu, M. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.902261 · Cited by 29
Kahn, E., Baarine, M., Dauphin, A., Ragot, K., Tissot, N., Seguin, A., Ménétrier, F., Kattan, Z., Bachelet, C., Frouin, F., et al. (2011) · Cytometry Part A · doi:10.1002/cyto.a.21017 · Cited by 30
Mitochondrial changes and oxidative stress in a mouse model of Zellweger syndrome neuropathogenesis
Rahim, R. S., Chen, M., Nourse, C. C., Meedeniya, A. C. B., & Crane, D. I. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.08.001 · Cited by 28
Vapola, M. H., Rokka, A., Sormunen, R. T., Alhonen, L. I., Schmitz, W., Conzelmann, E., Wärri, A. M., Grunau, S., Antonenkov, V. D., & Hiltunen, J. K. (2014) · Developmental Biology · doi:10.1016/j.ydbio.2014.03.022 · Cited by 28
Interferon regulatory factor 1 regulation of oligodendrocyte injury and inflammatory demyelination
Loda, E., & Balabanov, R. D. (2012) · Reviews in the Neurosciences · doi:10.1515/revneuro-2011-068 · Cited by 28
Kroner, A., Ip, C. W., Thalhammer, J., Nave, K., & Martini, R. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090722 · Cited by 28
Self-citationGoodenowe, D. B., Haroon, J. M., Kling, M. A., Zielinski, M. A., Mahdavi, K. D., Habelhah, B., Shtilkind, L., & Jordan, S. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.864842 · Cited by 28
RetractedExploring the roles of CD8+ T lymphocytes in the pathogenesis of autoimmune demyelination
Johnson, T., Jirik, F. R., & Fournier, S. (2010) · Seminars in Immunopathology · doi:10.1007/s00281-010-0199-7 · Cited by 25
Kashi, V. P., Ortega, S. B., & Karandikar, N. J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0105763 · Cited by 28
How neurons maintain their axons long-term: an integrated view of axon biology and pathology
Smith, G. A., Sweeney, S. T., O’Kane, C. J., & Prokop, A. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1236815 · Cited by 28
Neuroinflammation in white matter tracts of Cnp1 mutant mice amplified by a minor brain injury
Wieser, G. L., Gerwig, U. C., Adamcio, B., Barrette, B., Nave, K., Ehrenreich, H., & Goebbels, S. (2013) · Glia · doi:10.1002/glia.22480 · Cited by 26
Self-citationAbe, Y., Honsho, M., Itoh, R., Kawaguchi, R., Fujitani, M., Fujiwara, K., Hirokane, M., Matsuzaki, T., Nakayama, K., Ohgi, R., et al. (2018) · Life Science Alliance · doi:10.26508/lsa.201800062 · Cited by 24
Edgar, J. M., & Griffiths, I. R. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374709-9.00005-5 · Cited by 25
Evangelidou, M., Καραμίτα, Μ., Vamvakas, S. M., Szymkowski, D. E., & Probert, L. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1300633 · Cited by 24
Singh, J., Khan, M., Pujol, A., Baarine, M., & Singh, I. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070712 · Cited by 23
Remyelinating strategies in multiple sclerosis
Luessi, F., Kuhlmann, T., & Zipp, F. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.969241 · Cited by 24
Metadata
- Authors
- Kassmann, C. M., Lappe-Siefke, C., Baes, M., Brügger, B., Mildner, A., Werner, H. B., Natt, O., Michaelis, T., Prinz, M., Frahm, J., & Nave, K.-A.
- Affiliations
- Max Planck Institute of Experimental Medicine (DE)
- Max Planck Society (DE)
- KU Leuven (BE)
- Heidelberg University (DE)
- University of Göttingen (DE)
- Corresponding author
- Nave, Klaus-Armin
- ORCID
- Venue
- Nature Genetics
- Published
- 2007-07-22
- Volume
- 39
- Issue
- 8
- Pages
- 969-976
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W1971817019
- Cited by
- 357
- References
- 49
- Citations by year
- 2026: 13 · 2025: 12 · 2024: 19 · 2023: 20 · 2022: 12 · 2021: 14 · 2020: 16 · 2019: 7 · 2018: 18 · 2017: 15 · 2016: 17 · 2015: 14 · 2014: 20 · 2013: 31 · 2012: 28
- FWCI
- 17.46
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- GRO (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Keywords
- peroxisomes, oligodendrocytes, PEX5, axonal degeneration, demyelination, neuroinflammation, multiple sclerosis, white matter, myelination, neuroprotection, CD8+ T cells, B cells, demyelinating disease, mouse mutants
- MeSH terms
- Peroxisome-Targeting Signal 1 Receptor, Animals, Axons, Demyelinating Diseases, Humans, Nerve Fibers, Myelinated, Oligodendroglia, T-Lymphocyte Subsets, Receptors, Cytoplasmic and Nuclear, CD8-Positive T-Lymphocytes, Peroxisomes, Lipid Metabolism, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
